Literature DB >> 21045863

Experimental stroke-induced changes in the bone marrow reveal complex regulation of leukocyte responses.

Adam Denes1, Barry W McColl, Sophie F Leow-Dyke, Katie Z Chapman, Neil E Humphreys, Richard K Grencis, Stuart M Allan, Nancy J Rothwell.   

Abstract

Stroke induces a systemic response that involves rapid activation of inflammatory cascades, followed later by immunodepression. Experimental stroke-induced responses in the bone marrow, which is the primary source of circulating monocytes and granulocytes, have not been investigated previously. We show that cerebral ischaemia induced early (4  hours) release of CXCR2-positive granulocytes from the bone marrow, which was associated with rapid systemic upregulation of CXCL1 (a ligand for CXCR2) and granulocyte-colony-stimulating factor, a key cytokine involved in the mobilisation of bone marrow leukocytes. This process involves rapid activation of nuclear factor-κB and p38 mitogen-activated protein kinase in bone marrow myeloid cells. T-cell numbers in the bone marrow increased after stroke, and bone marrow cells did not show suppressed cytokine response to bacterial endotoxin stimulation in vitro. Stroke-induced laterality observed in the brain stem and in the bone marrow indicates direct involvement of the autonomic nervous system in stroke-induced cell mobilisation. We also show that systemic inflammatory changes and leukocyte responses in the bone marrow are profoundly affected by both anaesthetic and surgical stress. We conclude that stroke influences leukocyte responses in the bone marrow through multiple mechanisms and suggest that preclinical studies should take into consideration the effect of surgical manipulation in experimental models of stroke.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21045863      PMCID: PMC3070970          DOI: 10.1038/jcbfm.2010.198

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  53 in total

1.  Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro.

Authors:  H Matsuoka; S Kurosawa; T Horinouchi; M Kato; Y Hashimoto
Journal:  Anesthesiology       Date:  2001-12       Impact factor: 7.892

2.  Lateralisation of projections from the rostral ventrolateral medulla to sympathetic preganglionic neurons in the rat.

Authors:  Elizabeth A Moon; Ann K Goodchild; Paul M Pilowsky
Journal:  Brain Res       Date:  2002-03-08       Impact factor: 3.252

3.  NF-kappa B activation in tumor necrosis factor alpha-stimulated neutrophils is mediated by protein kinase Cdelta. Correlation to nuclear Ikappa Balpha.

Authors:  I Vancurova; V Miskolci; D Davidson
Journal:  J Biol Chem       Date:  2001-03-27       Impact factor: 5.157

4.  Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence.

Authors:  Coralie Martin; Peter C E Burdon; Gary Bridger; Jose Carlos Gutierrez-Ramos; Timothy J Williams; Sara M Rankin
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

5.  Neuropeptide control of bone marrow neutrophil production. A key axis for neuroimmunomodulation.

Authors:  C S Broome; J A Miyan
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

Review 6.  The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.

Authors:  I J Elenkov; R L Wilder; G P Chrousos; E S Vizi
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

7.  CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor.

Authors:  Marek Honczarenko; Yi Le; Aleksandra M Glodek; Marcin Majka; James J Campbell; Mariusz Z Ratajczak; Leslie E Silberstein
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

8.  Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.

Authors:  Christian Meisel; Konstantin Prass; Johann Braun; Ilya Victorov; Tilo Wolf; Dirk Megow; Elke Halle; Hans-Dieter Volk; Ulrich Dirnagl; Andreas Meisel
Journal:  Stroke       Date:  2003-12-18       Impact factor: 7.914

9.  Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4.

Authors:  Louis M Pelus; Huimin Bian; Andrew G King; Seiji Fukuda
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

10.  Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.

Authors:  Konstantin Prass; Christian Meisel; Conny Höflich; Johann Braun; Elke Halle; Tilo Wolf; Karsten Ruscher; Ilya V Victorov; Josef Priller; Ulrich Dirnagl; Hans-Dieter Volk; Andreas Meisel
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

View more
  30 in total

1.  Ischemic stroke activates hematopoietic bone marrow stem cells.

Authors:  Gabriel Courties; Fanny Herisson; Hendrik B Sager; Timo Heidt; Yuxiang Ye; Ying Wei; Yuan Sun; Nicolas Severe; Partha Dutta; Jennifer Scharff; David T Scadden; Ralph Weissleder; Filip K Swirski; Michael A Moskowitz; Matthias Nahrendorf
Journal:  Circ Res       Date:  2014-10-31       Impact factor: 17.367

Review 2.  Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions.

Authors:  Alicia García-Culebras; Violeta Durán-Laforet; Carolina Peña-Martínez; Iván Ballesteros; Jesús M Pradillo; Jaime Díaz-Guzmán; Ignacio Lizasoain; María A Moro
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-21       Impact factor: 6.200

3.  Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke.

Authors:  Bing Yang; Xiaopei Xi; Jaroslaw Aronowski; Sean I Savitz
Journal:  Stem Cells Dev       Date:  2012-08-03       Impact factor: 3.272

Review 4.  Inflammatory cytokines in experimental and human stroke.

Authors:  Kate Lykke Lambertsen; Knut Biber; Bente Finsen
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-27       Impact factor: 6.200

5.  Chronic Alterations in Systemic Immune Function after Traumatic Brain Injury.

Authors:  Rodney M Ritzel; Sarah J Doran; James P Barrett; Rebecca J Henry; Elise L Ma; Alan I Faden; David J Loane
Journal:  J Neurotrauma       Date:  2018-05-03       Impact factor: 5.269

Review 6.  Experimental intracerebral hemorrhage: avoiding pitfalls in translational research.

Authors:  Matthew A Kirkman; Stuart M Allan; Adrian R Parry-Jones
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-24       Impact factor: 6.200

7.  The impact of Ly6Clow monocytes after cerebral hypoxia-ischemia in adult mice.

Authors:  Jean-Philippe Michaud; Pedro Moreno Pimentel-Coelho; Yannick Tremblay; Serge Rivest
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-30       Impact factor: 6.200

8.  Evidence of bone marrow downregulation in brain-dead rats.

Authors:  Laura Menegat; Rafael Simas; Julia M Caliman; Fernando L Zanoni; Jacqueline F Jacysyn; Luiz Fernando F da Silva; Primavera Borelli; Luiz Felipe P Moreira; Paulina Sannomiya
Journal:  Int J Exp Pathol       Date:  2017-07-27       Impact factor: 1.925

9.  Early or Late Bacterial Lung Infection Increases Mortality After Traumatic Brain Injury in Male Mice and Chronically Impairs Monocyte Innate Immune Function.

Authors:  Sarah J Doran; Rebecca J Henry; Kari Ann Shirey; James P Barrett; Rodney M Ritzel; Wendy Lai; Jorge C Blanco; Alan I Faden; Stefanie N Vogel; David J Loane
Journal:  Crit Care Med       Date:  2020-05       Impact factor: 7.598

Review 10.  Efficacy of stem cell-based therapies for stroke.

Authors:  Matthew R Chrostek; Emily G Fellows; Andrew T Crane; Andrew W Grande; Walter C Low
Journal:  Brain Res       Date:  2019-08-02       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.